sarepta therapeutics inc
Edward M. Kaye M.D., Ph.D.
Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President, Sarepta Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 7 board members in 1 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Edward M. Kaye, also known as Ed, M.D. Ph.D., has been Chief Executive Officer of Sarepta Therapeutics, Inc since March 31, 2015. Dr. Kaye has been the Chief Medical Officer and Senior Vice President of Sarepta Therapeutics, Inc since June 20, 2011. Dr. Kaye serves as a Neurological Consultant at Children's Hospital of Boston. He has specific experience with pediatric neuromuscular conditions. Dr. Kaye joined AVI from Genzyme, where he served as Group Vice President ...
215 First StreetPhone: 617-274-4000
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
Loyola University of Chicago
Stritch School Of Medicine, Loyola University
|Ali Mortazavi||Chief Executive (leave of absence) and Director|
Silence Therapeutics plc
|Peter French B.Sc, M.Sc, Ph.D., MBA||Chief Executive Officer, Managing Director and Director|
Benitec Biopharma Limited
|Mark W. Schwartz Ph.D.||Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee|
Galena Biopharma, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|--||Compensation as of Fiscal Year 2014.|